Autoimmune Diseases Market in the US 2015-2019
About Autoimmune Diseases
Autoimmune diseases are caused by aggravation of the immune system. Autoimmune diseases can last for months or even years. Autoimmune reactions occur when the immune system produces autoantibodies that attack and destroy healthy tissues in the body rather than infectious agents. These autoantibodies cause inflammation, pain, and organ damage. It is also known as a disease of flare-ups and remissions, and can range from mild to life-threatening in severity. No cure exists for autoimmune diseases yet. Autoimmune diseases can affect the cardiovascular system, brain, nerves, musculoskeletal system, skin, lungs, kidneys, glands, or joints. They are caused by genetic, infectious, and environmental factors. According to NIH, there are more than 80 clinically different autoimmune diseases. Some of the common types of autoimmune diseases are ankylosing spondylitis, Crohn's disease, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, and psoriasis.
Technavio's analysts forecast the autoimmune diseases market in the US to grow at a CAGR of 6.17% over the period 2014-2019.
Covered in this Report
The report includes the present scenario and the growth prospects of the autoimmune diseases market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of autoimmune diseases.
Technavio's report, Autoimmune Diseases Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market size and forecast for individual diseases as well as the overall market and pipeline landscape. The report includes a discussion of the key vendors operating in this market.
Technavio Announces the Publication of its Research Report – Autoimmune Diseases Drugs Market in the US 2015-2019
Technavio recognizes the following companies as the key players in the Autoimmune Diseases Drugs Market in the US: AbbVie, Amgen, Biogen, F. Hoffmann-La Roche and Janssen Pharmaceuticals
Other Prominent Vendors in the market are: Bitdefender, Fortinet, F-Secure, G DATA Software, McAfee, Panda Security, PSafe, Sophos and Wontok
Commenting on the report, an analyst from Technavio’s team said: “Vendors are increasingly entering into alliances with universities, research institutes, and pharmaceutical companies for new drug development and to increase their market share. For instance, in 2015, Janssen-Cilag, a subsidiary of Janssen Pharmaceuticals, entered into an agreement with Monash University for the development of new medicines to treat rheumatoid arthritis and psoriasis. In 2014, MacroGenics and Takeda entered into an agreement for the development MGD010 for the treatment of systemic lupus erythematosus. In 2014, Kineta and Seattle Children's Research Institute announced the formation of an Alliance for Children's Therapeutics, a research collaboration for the development of new medicines in the treatment of autoimmune disorders such as multiple sclerosis and rheumatoid arthritis. Similarly, in 2013, Daiichi Sankyo and Amplimmune formed an alliance for the development of AMP-110, a biologic meant for the treatment of rheumatoid arthritis.”
According to the report, the high prevalence of autoimmune diseases is one of the major drivers in the market. An increasing number of people are being diagnosed with diseases such as Crohn's disease, multiple sclerosis, and rheumatoid arthritis. With the rise in the prevalence of autoimmune diseases, the demand for drugs is also increasing.Further, the report states that the complex nature of autoimmune diseases and the high cost of treatment are major challenges to the growth of the market.
AbbVie, Amgen, Biogen, F. Hoffmann-La Roche, Janssen Pharmaceuticals, Bitdefender, Fortinet, F-Secure, G DATA Software, McAfee, Panda Security, PSafe, Sophos, Wontok
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook